ziprasidone has been researched along with Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, S; Easwaran, M; Imtiyaz, K; Islam, M; Kizhakkeppurath Kumaran, A; Kurukkan Kunnath, A; Raza, K; Rizvi, MA; Sahu, A; Verma, S | 1 |
1 other study(ies) available for ziprasidone and Breast Neoplasms
| Article | Year |
|---|---|
In-silico and in-vitro study reveals ziprasidone as a potential aromatase inhibitor against breast carcinoma.
Topics: Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Proliferation; Female; Humans; Molecular Docking Simulation | 2023 |